Abbott Laboratories stock holds near USD 102 after July results

Published on 09/19/2026 at 12:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Abbott Laboratories stock traded at USD 102.35 on September 19, 2026, after June-quarter EPS of USD 1.31 beat estimates by USD 0.03. Revenue reached USD 12.59 billion, up 13.0 percent year over year.

Modernes Diagnostik-Labor Abbott Laboratories US0028241000 — Abbott Laboratories US0028241000 zeigt modernes Diagnostik-Labor mit Wissenschaftlern in weißen Laborkitteln an Analysesystemen, Illustration mit AI erstellt.

Abbott Laboratories stock (US0028241000) traded at USD 102.35 on September 19, 2026, after the June quarter brought EPS of USD 1.31 and revenue of USD 12.59 billion. In the same report, the company said revenue rose 13.0 percent year over year and EPS beat the consensus estimate by USD 0.03.

June quarter still sets the tone

According to MarketBeat, Abbott Laboratories reported quarterly revenue of USD 12.59 billion on July 16, 2026, versus analyst estimates of USD 12.52 billion. The same report put adjusted EPS at USD 1.31, compared with USD 1.26 a year earlier.

The market is also weighing guidance: according to MarketBeat, Abbott set Q3 2026 EPS guidance at USD 1.38 to USD 1.46 and FY 2026 guidance at USD 5.45 to USD 5.60. That leaves the full-year outlook centered above the current 2026 analyst consensus of USD 5.52 EPS cited in the same update.

Analysts remain positive

According to MarketBeat, BTIG Research raised its target to USD 134 from USD 131 on July 17, 2026, while Wolfe Research lifted Abbott to outperform with a USD 130 target on August 13, 2026. MarketBeat also cited a consensus target of USD 119.50, above the latest quoted share price.

For investors, the gap matters more than the headline rating. The latest quote of USD 102.35 sits below the consensus target by USD 17.15 and well below BTIG's USD 134 objective.

Price stays below targets

Abbott Laboratories stock changed hands at USD 102.35 on September 19, 2026, with a market capitalization of USD 177.11 billion and a 52-week range of USD 81.97 to USD 137.49. The gap to the 52-week high is USD 35.14, and the share price remains above the low by USD 20.38.